Testing Liquid Samples to Monitor HPV-Linked Cancers During Treatment
Checks liquid samples for HPV in adults with cervical or throat cancers.
Plain-language title generated from the registry record
Registry title: Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Key facts
- Where
- Olomouc, CzechiaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT05774561, who can take part
Where in Czechia
- University Hospital OlomoucOlomouc, CzechiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Institute of Molecular and Translational Medicine, Czech Republic
- Trial code
- NCT05774561
- Record updated
- 5 November 2026
- Original description
This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.Read full original descriptionShow less
Liquid Biopsies - a Possible Tool for Treatment Monitoring and Early Recurrence Detection in HPV-associated Diseases
This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.
Inclusion: Women diagnosed with CC/HSIL. Men and women diagnosed with OPC. Patients must agree with study enrollment and must sign study informed consent.
Exclusion: No exclusion criteria are set.